Article Details

Resistance Mechanisms to FLT3 Inhibitor for AML Characterized Using Mission Bio's Tapestri ...

Retrieved on: 2021-03-10 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Resistance Mechanisms to FLT3 Inhibitor for AML Characterized Using Mission Bio's Tapestri .... View article details on hiswai:

Excerpt

Founded in 2014, Mission Bio has secured investment from Novo Growth, Cota Capital, Agilent Technologies, Mayfield Fund, and others.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up